PISANI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 79.901
AS - Asia 8.379
EU - Europa 6.084
SA - Sud America 1.184
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 29
OC - Oceania 15
Totale 95.678
Nazione #
US - Stati Uniti d'America 79.716
SG - Singapore 4.014
CN - Cina 1.550
UA - Ucraina 1.053
BR - Brasile 971
HK - Hong Kong 945
RU - Federazione Russa 919
DE - Germania 837
IT - Italia 837
IE - Irlanda 815
VN - Vietnam 537
KR - Corea 463
FR - Francia 386
SE - Svezia 317
GB - Regno Unito 311
FI - Finlandia 249
BD - Bangladesh 218
JP - Giappone 199
IN - India 104
CA - Canada 96
NL - Olanda 86
AR - Argentina 81
PL - Polonia 63
ID - Indonesia 56
MX - Messico 48
TR - Turchia 40
ES - Italia 39
IQ - Iraq 37
AT - Austria 31
EC - Ecuador 31
CL - Cile 28
BE - Belgio 27
EU - Europa 26
ZA - Sudafrica 24
CZ - Repubblica Ceca 19
TH - Thailandia 19
KG - Kirghizistan 18
PK - Pakistan 17
CO - Colombia 16
PY - Paraguay 16
VE - Venezuela 16
CH - Svizzera 15
AE - Emirati Arabi Uniti 14
JO - Giordania 14
UZ - Uzbekistan 14
AU - Australia 13
KE - Kenya 13
IR - Iran 12
PH - Filippine 12
LT - Lituania 11
NP - Nepal 11
SA - Arabia Saudita 11
MY - Malesia 10
PT - Portogallo 10
RO - Romania 10
TN - Tunisia 10
AL - Albania 9
DZ - Algeria 9
IL - Israele 9
MA - Marocco 9
PE - Perù 8
TW - Taiwan 8
UY - Uruguay 8
AZ - Azerbaigian 7
EG - Egitto 7
GE - Georgia 7
KZ - Kazakistan 7
BO - Bolivia 6
GR - Grecia 6
HN - Honduras 6
OM - Oman 6
SK - Slovacchia (Repubblica Slovacca) 6
DM - Dominica 5
NG - Nigeria 5
CR - Costa Rica 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
KW - Kuwait 4
LB - Libano 4
MT - Malta 4
PR - Porto Rico 4
RS - Serbia 4
BY - Bielorussia 3
JM - Giamaica 3
NI - Nicaragua 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
GY - Guiana 2
HR - Croazia 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
BG - Bulgaria 1
Totale 95.655
Città #
Woodbridge 22.872
Wilmington 20.333
Houston 18.821
Fairfield 2.674
Singapore 1.984
Ann Arbor 1.796
Ashburn 1.519
Seattle 1.082
Chandler 1.005
Jacksonville 944
Hong Kong 932
Cambridge 914
San Jose 860
Dublin 758
Medford 547
Beijing 529
Dearborn 365
Santa Clara 352
New York 317
The Dalles 286
Lawrence 261
Rome 242
Los Angeles 213
Menlo Park 196
Tokyo 164
Moscow 162
Buffalo 160
Lauterbourg 160
Ho Chi Minh City 157
Zhengzhou 146
Council Bluffs 136
Hanoi 136
San Diego 99
São Paulo 96
Dallas 94
Milan 89
Mülheim 82
Munich 68
London 61
Norwalk 48
Nanjing 47
North Bergen 46
Mountain View 45
University Park 45
Shanghai 44
Chicago 42
Rio de Janeiro 42
Hefei 41
Helsinki 40
Orem 40
Redondo Beach 40
Falls Church 36
Guangzhou 35
Verona 35
Redwood City 34
Warsaw 34
Kunming 33
Detroit 30
Brooklyn 29
Montreal 29
Nuremberg 29
Atlanta 28
Mcallen 28
San Mateo 28
Jakarta 27
Columbus 26
Phoenix 26
Saint Petersburg 26
Frankfurt am Main 25
Brussels 24
Belo Horizonte 23
Palo Alto 23
Amsterdam 22
Da Nang 22
Redmond 22
Stockholm 22
Toronto 21
Denver 20
Kraków 20
Monmouth Junction 20
Hangzhou 19
Mumbai 19
San Francisco 19
Chennai 18
Manchester 18
Boardman 17
Brno 17
Genoa 17
Mexico City 17
Porto Alegre 17
Seoul 17
Brasília 15
Dhaka 15
Johannesburg 15
Salvador 15
Baghdad 14
Bangkok 14
Campinas 14
Haiphong 14
Vienna 14
Totale 83.234
Nome #
Strength and weaknesses of cerebrospinal fluid biomarkers in Alzheimer's disease and possible detection of overlaps with frailty process 636
Neuroacanthocytosis associated with a defect of the 4.1R membrane protein 521
Early synaptic dysfunction in Parkinson's disease: Insights from animal models 510
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 497
Inhibition of persistent sodium current fraction and voltage-gated L-type calcium current by propofol in cortical neurons: Implications for its antiepileptic activity 489
Aberrant striatal synaptic plasticity in monogenic parkinsonisms 489
Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia 486
Age-related functional changes of high-voltage-activated calcium channels in different neuronal subtypes of mouse striatum 484
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 484
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 481
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease 477
Subtle alterations of excitatory transmission are linked to presynaptic changes in the hippocampus of PINK1-deficient mice 477
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain 475
Muscarinic IPSPs in rat striatal cholinergic interneurones 474
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease 471
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 469
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 468
Synaptic transmission in the striatum: from plasticity to neurodegeneration 468
Homeostatic changes of the endocannabinoid system in Parkinson's disease. 467
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 466
Abnormal plasticity in dystonia: Disruption of synaptic homeostasis 466
Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum 465
Distinct roles of group I mGlu receptors in striatal function 465
Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: Role of M1 muscarinic receptors 465
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 464
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 464
Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia 463
Optogenetic stimulation reveals distinct modulatory properties of thalamostriatal vs corticostriatal glutamatergic inputs to fast-spiking interneurons 462
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 461
Early abnormalities in 123I-ioflupane (DaTSCAN) imaging in the fragile X-associated tremor ataxia syndrome (FXTAS): a case report 460
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 457
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease 457
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 455
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases 452
Seletracetam (ucb 44212) inhibits high-voltage-activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro 452
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 451
Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons 451
The Italian Dystonia Registry: rationale, design and preliminary findings 450
Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons 449
Occurrence of Writing Tremor in Patients With Scans Without Evidence of Dopaminergic Deficit 449
Re-emergence of striatal cholinergic interneurons in movement disorders 448
An investigation of hearing impairment in de-novo Parkinson's disease patients: A preliminary study 448
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine 447
Striatal synaptic plasticity: implications for motor learning and Parkinson's disease 443
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice 442
Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons 441
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease. 440
Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine 439
Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia 439
Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD) 439
Putaminal, but not nigral alterations, characterize hemiparkinsonism-hemiatrophy syndrome: a case report 438
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. 438
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease 437
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons 435
Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation 433
Centrality of striatal cholinergic transmission in Basal Ganglia function 433
Pisa syndrome in Parkinson disease: An observational multicenter Italian study 433
Hyperkinetic disorders and loss of synaptic downscaling 433
Synaptic plasticity in the ischaemic brain 432
An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons 432
Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine 432
Facial diplegia resembling bilateral Ramsay Hunt Syndrome 432
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial parkinsonism-linked gene DJ-1 430
Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity 430
Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons 430
PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity 430
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 430
Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation 429
Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders 429
Behavioural learning-induced increase in spontaneous GABAA-dependent synaptic activity in rat striatal cholinergic interneurons 429
Long-term synaptic depression in the striatum: physiological and pharmacological characterization 429
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 429
Effects of two weeks of cerebellar theta burst stimulation in cervical dystonia patients 428
Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine 427
CSF biomarkers in superficial siderosis: a new tool for diagnosis and evaluation of therapeutic efficacy of deferiprone--a case report 427
Role of Ca2+ in striatal LTD and LTP 426
Vulnerability of medium spiny striatal neurons to glutamate: role of Na+/K+ ATPase 426
Engineering animal models of dystonia 426
Double hit mouse model of Parkinson's disease 426
Outward potassium currents activated by depolarization in rat globus pallidus 425
Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity 424
Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability 424
Morphological and functional study of dwarf neurons in the rat striatum 424
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase 424
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine 423
Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons 423
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons 423
Persistent chorea in DYT6, due to anticholinergic therapy 423
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors 422
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life 421
Involvement of intracellular calcium stores during oxygen/glucose deprivation in striatal large aspiny interneurons 420
Transmitter release associated with long-term synaptic depression in rat corticostriatal slices 420
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons 419
Pathological synaptic plasticity in the striatum: implications for Parkinson's disease 418
The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia 418
Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin 418
Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease 417
Electrophysiology of 5-HT6 receptors 417
Tissue plasminogen activator is required for corticostriatal long-term potentiation 415
Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors 415
Totale 44.695
Categoria #
all - tutte 213.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 213.645


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021153 0 0 0 0 0 0 0 0 0 0 0 153
2021/20222.632 112 215 127 148 39 280 252 114 152 294 148 751
2022/20232.836 365 221 79 316 202 765 264 151 228 6 167 72
2023/2024983 108 34 66 20 89 234 39 110 66 21 4 192
2024/20256.039 147 1.447 643 321 155 430 370 226 485 484 769 562
2025/20268.679 694 446 1.095 685 728 264 1.027 1.183 959 803 459 336
Totale 96.489